Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Paratek Pharmaceuticals Announced That The European Medicines Agency Committee For Orphan Medicinal Products Has Recommended Positive Opinion For Orphan Medicinal Product Designation For Nuzyra (Omadacycline) For Nontuberculous Mycobacterial Lung Disease

Author: Benzinga Newsdesk | June 27, 2023 08:06am

Posted In: PRTK